CTX110 Allogeneic CRISPR-Cas9-Engineered CAR T Cells in Patients (Pts) with Relapsed or Refractory (R/R) Large B-Cell Lymphoma (LBCL): Results from the Phase 1 Dose Escalation Carbon Study

Joseph P McGuirk, Constantine S Tam, Nicolaus Kroeger, Peter A Riedell, Hemant S Murthy, Phoebe Joy Ho, Joseph E Maakaron, Edmund K Waller, Farrukh T Awan, Paul J Shaughnessy, Armin Ghobadi, Michael R Bishop, Ana Alfonso-Pierola, Michael Dickinson, Praveen Ramakrishnan Geethakumari, Ainsley Ross, William Stevens, Huansheng Xu, Anna Ma, Sarah Beaussant Cohen Show all